|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics
2020:GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Wagle NS and Jemal
A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McGuigan A, Kelly P, Turkington RC, Jones
C, Coleman HG and McCain RS: Pancreatic cancer: A review of
clinical diagnosis, epidemiology, treatment and outcomes. World J
Gastroenterol. 24:4846–4861. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grant TJ, Hua K and Singh A: Molecular
pathogenesis of pancreatic cancer. Prog Mol Biol Transl Sci.
144:241–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kern SE, Hruban RH, Hidalgo M and Yeo CJ:
An introduction to pancreatic adenocarcinoma genetics, pathology
and therapy. Cancer Biol Ther. 1:607–613. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Visvader JE and Lindeman GJ: Cancer stem
cells: Current status and evolving complexities. Cell Stem Cell.
10:717–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie
MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al: Association
of reactive oxygen species levels and radioresistance in cancer
stem cells. Nature. 458:780–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nozaki Y, Tamori S, Inada M, Katayama R,
Nakane H, Minamishima O, Onodera Y, Abe M, Shiina S, Tamura K, et
al: Correlation between c-Met and ALDH1 contributes to the survival
and tumor-sphere formation of ALDH1 positive breast cancer stem
cells and predicts poor clinical outcome in breast cancer. Genes
Cancer. 8:628–639. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim MP, Fleming JB, Wang H, Abbruzzese JL,
Choi W, Kopetz S, McConkey DJ, Evans DB and Gallick GE: ALDH
activity selectively defines an enhanced tumor-initiating cell
population relative to CD133 expression in human pancreatic
adenocarcinoma. PLoS One. 6:e206362011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rasheed ZA, Yang J, Wang Q, Kowalski J,
Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, et
al: Prognostic significance of tumorigenic cells with mesenchymal
features in pancreatic adenocarcinoma. J Natl Cancer Inst.
102:340–351. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim SK, Kim H, Lee DH, Kim TS, Kim T,
Chung C, Koh GY, Kim H and Lim DS: Reversing the intractable nature
of pancreatic cancer by selectively targeting ALDH-high,
therapy-resistant cancer cells. PLoS One. 8:e781302013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marcato P, Dean CA, Giacomantonio CA and
Lee PWK: Aldehyde dehydrogenase: Its role as a cancer stem cell
markaer comes down to the specific isoform. Cell Cycle.
10:1378–1384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shingh S, Arcaroli J, Thompson DC,
Messersmith W and Vasiliou V: Acetaldehyde and
retinaldehyde-metabolizing enzymes in colon and pancreatic cancers.
Adv Exp Med Biol. 815:281–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
McLean ME, McLean MR, Cahill HF, Arun RP,
Walker OL, Wasson MCD, Fernando W, Venkatesh J and Marcato P: The
expanding role of cancer stem cell marker ALDH1A3 in cancer and
beyond. Cancers (Basel). 15:4922023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kasai T, Tamori S, Takasaki Y, Matsuoka I,
Ozaki A, Matsuda C, Harada Y, Sasaki K, Ohno S and Akimoto K: High
expression of PKCλ and ALDH1A3 indicates a poor prognosis, and PKCλ
is required for the asymmetric cell division of ALDH1A3-positive
cancer stem cells in PDAC. Biochem Biophys Res Commun. 669:85–94.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jia J, Parikh H, Xiao W, Hoskins JW,
Pflicke H, Liu X, Collins I, Zhou W, Wang Z, Powell J, et al: An
integrated transcriptome and epigenome analysis identifies a novel
candidate gene for pancreatic cancer. BMC Medical Genom. 6:332013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nie S, Qian X, Shi M, Li H, Peng C, Ding
X, Zhang S, Zhang B, Xu G, Lv Y, et al: ALDH1A3 accelerates
pancreatic cancer metastasis by promoting glucose metabolism. Flont
Oncol. 10:9152020. View Article : Google Scholar
|
|
20
|
Johann SV, Gibbons JJ and O'Hara B: GLVR1,
a receptor for gibbon ape leukemia virus, is homologous to a
phosphate permease of Neurospora crassa and is expressed at high
levels in the brain and thymus. J Virol. 66:1635–1640. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kavanaugh MP, Miller DG, Zhang W, Law W,
Kozak SL, Kabat D and Miller AD: Cell-surface receptors for gibbon
ape leukemia virus and amphotropic murine retrovirus are inducible
sodium-dependent phosphate symporters. Proc Natl Acad Sci USA.
91:7071–7075. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Onaga C, Tamori S, Matsuoka I, Ozaki A,
Motomura H, Nagashima Y, Sato T, Sato K, Xiong Y, Sasaki K, et al:
High expression of SLC20A1 is less effective for endocrine therapy
and predicts late recurrence in ER-positive breast cancer. PLoS
One. 17:e02687992022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Onaga C, Tamori S, Motomura H, Ozaki A,
Matsuda C, Matsuoka I, Fujita T, Nozaki Y, Hara Y, Kawano Y, et al:
High SLC20A1 expression is associated with poor prognoses in
claudin-low and basal-like breast cancers. Anticancer Res.
41:43–54. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Onaga C, Tamori S, Matsuoka I, Ozaki A,
Motomura H, Nagashima Y, Sato T, Sato K, Tahata K, Xiong Y, et al:
High SLC20A1 expression is associated with poor prognosis for
radiotherapy of estrogen receptor-positive breast cancer. Cancer
Diagn Progn. 2:429–442. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Haider S, Wang J, Nagano A, Desai A,
Arumugam P, Dumartin L, Fitzgibbon J, Hagemann T, Marshall JF,
Kocher HM, et al: A multi-gene signature predicts outcome in
patients with pancreatic ductal adenocarcinoma. Genome Med.
6:1052014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Canlı SD, Dedeoğlu E, Akbar MW,
Küçükkaraduman B, İşbilen M, Erdoğan ÖŞ, Erciyas SK, Yazıcı H,
Vural B and Güre AO: A novel 20-gene prognostic score in pancreatic
adenocarcinoma. PLoS One. 15:e02318352020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ouyang J, Hu Z, Tong J, Yang Y, Wang J,
Chen X, Luo T, Yu S, Wang X and Huang S: Construction and
evaluation of a nomogram for predicting survival in patients with
lung cancer. Aging (Albany NY). 14:2775–2792. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Okamoto T, Onaga C, Matsuoka I, Ozaki A,
Matsuda C, Kasai T, Xiong Y, Harada Y, Sato T, Nakano Y, et al:
High SLC20A1 expression indicates poor prognosis in prostate
cancer. Cancer Diagn Progn. 3:439–448. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sato K and Akimoto K: Expression levels of
KMT2C and SLC20A1 identified by information-theoretical analysis
are powerful prognostic biomarkers in estrogen receptor-positive
breast cancer. Clin Breast Cancer. 17:e135–e142. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen T, Wang M and Wang X: Identification
of prognosis-related Hub RNA binding proteins function through
regulating metabolic processes in tongue cancer. J Cancer.
12:2230–2242. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dong Z, Wang J, Zhan T and Xu S:
Identification of prognostic risk factors for esophageal
adenocarcinoma using bioinformatics analysis. Onco Targets Ther.
11:4327–4337. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Salaün C, Leroy C, Rousseau A, Boitez V,
Beck L and Friedlander G: Identification of a novel
transport-independent function of PiT1/SLC20A1 in the regulation of
TNF-induced apoptosis. J Biol Chem. 285:34408–34418. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Beck L, Leroy C, Salaün C, Margall-Ducos
G, Desdouets C and Friedlander G: Identification of a novel
function of PiT1 critical for cell proliferation and independent of
its phosphate transport activity. J Biol Chem. 284:31363–31374.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Byskov K, Jensen N, Kongsfelt IB, Wielsøe
M, Pedersen LE, Haldrup C and Pedersen L: Regulation of cell
proliferation and cell density by the inorganic phosphate
transporter PiT1. Cell Div. 7:72012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cancer Genome Atlas Research Network, .
Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA,
Ellrott K, Shmulevich I, Sander C and Stuart JM: The cancer genome
atlas pan-cancer analysis project. Nat Genet. 45:1113–1120. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hoadley KA, Yau C, Hinoue T, Wolf DM,
Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, et
al: Cell-of-origin patterns dominate the molecular classification
of 10,000 tumors from 33 types of cancer. Cell. 173:291–304. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: an open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larssson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nozaki Y, Motomura H, Tamori S, Kimura Y,
Onaga C, Kanai S, Ishihara Y, Ozaki A, Hara Y, Harada Y, et al:
High PKCλ expression is required for ALDH1-positive cancer stem
cell function and indicates a poor clinical outcome in late-stage
breast cancer patients. PLoS One. 15:e02357472020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Motomura H, Tamori S, Yatani MK, Namiki A,
Onaga C, Ozaki A, Takasawa R, Mano Y, Sato T, Hara Y, et al: GLO 1
and PKCλ regulate ALDH1-positive breast cancer stem cell survival.
Anticancer Res. 41:5959–5971. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ozaki A, Motomura H, Tamori S, Onaga C,
Nagashima Y, Kotori M, Matsuda C, Matsuda A, Mochizuki N, Sato T,
et al: High expression of p62 and ALDH1A3 is associated with poor
prognosis in luminal b breast cancer. Anticancer Res. 42:3299–3312.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xiong Y, Motomura H, Tamori S, Ozaki A,
Onaga C, Hara Y, Sato K, Tahata K, Harada Y, Sasaki K, et al: High
expression of CD58 and ALDH1A3 predicts a poor prognosis in
basal-like breast cancer. Anticancer Res. 42:5223–5232. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tamori S, Nozaki Y, Motomura H, Nakane H,
Katayama R, Onaga C, Kikuchi E, Shimada N, Suzuki Y, Noike M, et
al: Glyoxalase 1 gene is highly expressed in basal-like human
breast cancers and contributes to survival of ALDH1-positive breast
cancer stem cells. Oncotarget. 9:36515–36529. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Motomura H, Ozaki A, Tamori S, Onaga C,
Nozaki Y, Waki Y, Takasawa R, Yoshizawa K, Mano Y, Sato T, et al:
Glyoxalase 1 and protein kinase Cλ as potential therapeutic targets
for late-stage breast cancer. Oncol Lett. 22:5472021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Connor AA and Gallinger S: Pancreatic
cancer evolution and heterogeneity: Integrating omics and clinical
data. Nat Rev Cancer. 22:131–142. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hong SP, Wen J, Bang S, Park S and Song
SY: CD44-positive cells are responsible for gemcitabine resistance
in pancreatic cancer cells. Int J Cancer. 125:2323–2331. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations
of cancer stem cells determine tumor growth and metastatic activity
in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Maeda S, Shinchi H, Kurahara H, Mataki Y,
Maemura K, Sato M, Natsugoe S, Aikou T and Takao S: CD133
expression is correlated with lymph node metastasis and vascular
endothelial growth factor-C expression in pancreatic cancer. Br J
Cancer. 98:1389–1397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Beck L, Leroy C, Cormier SB, Forand A,
Salaün C, Paris N, Bernier A, Ureña-Torres P, Prié D, Ollero M, et
al: The phosphate transporter PiT1 (Slc20a1) revealed as a new
essential gene for mouse liver development. PLoS One. 5:e91482010.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Marcato P, Dean CA, Liu RZ, Coyle KM,
Bydoun M, Wallace M, Clements D, Turner C, Mathenge EG, Gujar SA,
et al: Aldehyde dehydrogenase 1A3 influences breast cancer
progression via differential retinoic acid signaling. Mol Oncol.
9:17–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
